Scheme 1From: Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancerIllustrations for A preparation of TIR@siRNA nanoparticles and B their functional mechanisms against colorectal cancer via gene enhanced nuclear-targeted SDT boost anti-PD-L1 therapy in vitro and in vivoBack to article page